Razan Asaad
Internal Medicine · Allentown, PANPI 1497048391
Payments from drug & device makers
Across 149 payments — averaging $56.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Novo Nordisk$660
- Amgen$410
- AstraZeneca$331
- Lundbeck LLC$210
- Teva Pharmaceuticals USA, Inc.$200
- plus $812 from 11 others
What the payments were for
- Speaking & faculty fees$5,05060%
- Food & beverage$3,25738%
- Education$1702%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 49 | $5,853 |
| Novo Nordisk | 28 | $660 |
| Amgen(2 entities) | 23 | $410 |
| AstraZeneca(2 entities) | 10 | $331 |
| Lundbeck LLC | 4 | $210 |
| Teva Pharmaceuticals USA, Inc. | 4 | $200 |
| Boehringer Ingelheim | 6 | $179 |
| Pfizer | 10 | $154 |
| Esperion Therapeutics, Inc. | 2 | $140 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $66 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Astellas Pharma US Inc | 2 | $34 |
| Phadia US Inc. | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,477 in reported general payments places this provider in the 90th percentile of 5,705 internal medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 11 | $10,469 |
| Oxcarbazepine | 12 | $915 |
| Gabapentin | 37 | $376 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $154 | $10,46911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Allentown
- Joseph YozviakAllentown$1.1M
- Eric MuellerAllentown$585K
- Jonathan EpsteinPhiladelphia$13.1M
- Siddharth ShethPittsburgh$11M
- Nathan PatelTannersville$9.5M
- Pitamber DevgonPhiladelphia$7.5M
- Christopher StillDanville$7.1M
- Liza VillaruzPittsburgh$6.6M
- Paul HartleyUniontown$4.9M
- Victor KoladeSayre$4.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.